close
MENU
Law
2 mins to read

Fed-up customers sue Sudafed maker Johnson & Johnson

Law firm JGA Saddler rolls out big class action against Johnson & Johnson, on basis that Sudafed and Codral’s main ingredient is ‘ineffective’.

WATCH: JGA Saddler director Rebecca Jancauska speaks with NBR.

‘Phenylephrine’ simply doesn't work, is the drum being beaten by class action firm JGA Saddler in its litigation against multinational Johnson & Johnson.

The law firm, which was lodging the action on behalf of "millions" of New Zealanders in Auckland High Court on Thursday, was taking on the

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Smartphone Only Annual Subscription

NZ$249.00 / yearly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Subscription

NZ$29.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Brent Melville Thu, 13 Feb 2025
Contact the Writer: bmelville@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Fed-up customers sue Sudafed maker Johnson & Johnson
Law,
107763
true